InvestWiser

Monsenso A/S

MONSONasdaq CopenhagenHealthcareMarket value 18 m DKK
0.18DKK +0.6%
last day · Price as of 18 November 2026

The answer first

Does Monsenso beat the market?

Yes, Monsenso has beaten the market over the last year.

Monsenso+31.9%København (OMXCGI)+13.9%
  • The ranking · Quality, value and trend combined

    Better than 18% of Nordic stocks

    • Quality46
    • Value16
    • Trend39

    No. 137 of 195 in healthcare

Max for seven days

Follow Monsenso with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Monsenso

From today, at a price of 0.18 DKK. Write why you follow Monsenso, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Monsenso

Your first answer is free, no account needed.

Do you own Monsenso, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Monsenso and a few more. Free, no card.

Past year against the exchange and Super Stock
Monsenso+80.2%København (OMXCGI)+13.9%Super Stock+44.6%
29 October 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Monsenso has risen 31.9% over the past year, including dividends.
  • Overall, Monsenso ranks better than 18% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 98.5%. The price is 99.1% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

18

Quality, value and trend together. Better than 18% of Nordic stocks.

No. 137 of 195 in healthcare

Quality46
The company · Fundamentals: the accounts

Medium An average company: the accounts are neither especially strong nor weak.

No. 136 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.13
  • Asset turnoverSales divided by everything the company owns0.66
  • Return on equityProfit divided by equity−100.9%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value16
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 113 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity2.5
  • P/SPrice divided by sales2.4
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend39
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 85 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−27.8%
  • 6 months−24.2%
  • 9 months+35.8%
  • 12 months+31.9%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−17.3%
3 years, per year
−20.5%
5 years, per year
−49.4%
Year to date
+21.3%
Largest fall, 3 years
−98.5%
From a peak to the bottom
From the peak now
−99.1%
How far the price is from the peak
Volatility, 1 year
201.7%
How much the price swings over a year
Beta, 1 year
0.37
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Monsenso

4 funds we follow own Monsenso. The share is how much of the fund the stock makes up.

  • Denmark4

From the funds' latest known holdings.

About Monsenso

Monsenso A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 9 employees.

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes.

See the full analysis of Monsenso.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Copenhagen

Explore the stock market